GENE ONLINE|News &
Opinion
Blog

Clostridium Difficile
OpenBiome and the University of Minnesota collaborate to give Microbes to those in Need
2022-01-26
Australia’s BiomeBank Seeks Approval for the World’s First Microbial Therapy
2021-07-04
Caloric Restriction Works Beyond Weight Loss, Alters Gut Microbiome
2021-06-27
R&D
BARDA Funds Development of Live Biotherapeutic Product Against C. difficile Infections
2020-10-05
Seres Therapeutics’ Microbiome Therapy for Recurrent C. difficile Infections, Shines in Phase 3
2020-08-12
Finch’s First Microbial Cocktail Treating Clostridium Infection Registers Positive Results
2020-06-24
Rebiotix, Ferring Announces Positive Phase 3 Data of World’s First Microbiome-Based Therapeutic
2020-05-09
LATEST
Bayer’s NUBEQA: Breakthrough in Prostate Cancer with 46% Risk Reduction and Future FDA Expansion Plans
2024-09-19
Highlights from ESMO 2024: Key Oncology Advances from Major Pharmaceutical Companies
2024-09-19
Five Biotech Stocks Soar: Eyes on Halozyme, United Therapeutics, Harmony, Ligand, and ADMA
2024-09-19
Biotech Industry Trends in 2024: A Look at the Billions in Oncology Deals
2024-09-18
Thailand’s Biotech Boom: Innovations in Precision Medicine, Cell Therapy, and Wellness Drive APAC Leadership
2024-09-18
International Green Party Showcases AI Solutions for a Healthy and Sustainable Future
2024-09-16
Bio Asia Pacific 2024 Close ASEAN Collaborations: Catalyzing Innovation and Global Partnerships
2024-09-12
EVENT
2024-10-09
Medical Japan 2024 Tokyo
Tokyo, Japan
2024-10-15
BIO Investor Forum 2024
San Francisco, U.S.A.
Scroll to Top